__timestamp | Ligand Pharmaceuticals Incorporated | Taro Pharmaceutical Industries Ltd. |
---|---|---|
Wednesday, January 1, 2014 | 64538000 | 759285000 |
Thursday, January 1, 2015 | 71914000 | 862944000 |
Friday, January 1, 2016 | 108973000 | 950751000 |
Sunday, January 1, 2017 | 141102000 | 879387000 |
Monday, January 1, 2018 | 251453000 | 661913000 |
Tuesday, January 1, 2019 | 120282000 | 669893000 |
Wednesday, January 1, 2020 | 186419000 | 644769000 |
Friday, January 1, 2021 | 277133000 | 548970000 |
Saturday, January 1, 2022 | 196245000 | 561347000 |
Sunday, January 1, 2023 | 131314000 | 572952000 |
Monday, January 1, 2024 | 629182000 |
Igniting the spark of knowledge
In the competitive landscape of pharmaceuticals, Ligand Pharmaceuticals Incorporated and Taro Pharmaceutical Industries Ltd. have showcased contrasting revenue trajectories over the past decade. From 2014 to 2023, Taro consistently outperformed Ligand, with revenues peaking at approximately $950 million in 2016, a stark contrast to Ligand's highest revenue of around $277 million in 2021. This represents a revenue ratio where Taro's earnings were often more than three times that of Ligand's. However, both companies faced revenue declines in recent years, with Taro's revenue dropping by about 40% from its peak, while Ligand saw a 53% increase from 2014 to 2021 before a subsequent decline. Notably, 2024 data for Ligand is missing, leaving room for speculation on its future performance. These trends highlight the dynamic nature of the pharmaceutical industry and the varying strategies companies employ to navigate it.
Revenue Showdown: Novartis AG vs Taro Pharmaceutical Industries Ltd.
Breaking Down Revenue Trends: BeiGene, Ltd. vs Taro Pharmaceutical Industries Ltd.
Revenue Insights: Halozyme Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated Performance Compared
Who Generates More Revenue? Lantheus Holdings, Inc. or Taro Pharmaceutical Industries Ltd.
Who Generates More Revenue? Cytokinetics, Incorporated or Ligand Pharmaceuticals Incorporated
Breaking Down Revenue Trends: Ionis Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Revenue Insights: Alkermes plc and Ligand Pharmaceuticals Incorporated Performance Compared
Revenue Insights: TG Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd. Performance Compared
Annual Revenue Comparison: Ligand Pharmaceuticals Incorporated vs Evotec SE
Mesoblast Limited or Taro Pharmaceutical Industries Ltd.: Who Leads in Yearly Revenue?
Breaking Down Revenue Trends: Taro Pharmaceutical Industries Ltd. vs Novavax, Inc.
Annual Revenue Comparison: Taro Pharmaceutical Industries Ltd. vs MiMedx Group, Inc.